Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/4998
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSome, Fatuma-
dc.contributor.authorKoech, Mathew-
dc.contributor.authorChesire, Emily-
dc.contributor.authorKigen, Gabriel-
dc.date.accessioned2021-08-10T09:09:40Z-
dc.date.available2021-08-10T09:09:40Z-
dc.date.issued2017-
dc.identifier.urihttps://www.ajol.info/index.php/pamj/article/view/159918-
dc.identifier.urihttp://ir.mu.ac.ke:8080/jspui/handle/123456789/4998-
dc.description.abstractThe use of the antiretroviral drug tenofovir has been associated with nephrotoxicity. However, the overall impact of this adverse effect has not been comprehensively evaluated. Some researchers have reported that it is quite severe to warrant monitoring for renal toxicity, while others have concluded that the magnitude may not be that significant. We report two clinical cases seen in our renal clinic with high creatinine levels suggestive of nephrotoxicity who reverted back to normality upon withdrawal of tenofovir.en_US
dc.language.isoenen_US
dc.publisherAJOLen_US
dc.subjectHIV/AIDSen_US
dc.subjectNephrotoxicityen_US
dc.subjectTenofoviren_US
dc.titleReversal of tenofovir induced nephrotoxicity: case reports of two patientsen_US
dc.typeArticleen_US
Appears in Collections:School of Medicine

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.